Literature DB >> 10888618

The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.

J J Coull1, F Romerio, J M Sun, J L Volker, K M Galvin, J R Davie, Y Shi, U Hansen, D M Margolis.   

Abstract

Enigmatic mechanisms restore the resting state in activated lymphocytes following human immunodeficiency virus type 1 (HIV-1) infection, rarely allowing persistent nonproductive infection. We detail a mechanism whereby cellular factors could establish virological latency. The transcription factors YY1 and LSF cooperate in repression of transcription from the HIV-1 long terminal repeat (LTR). LSF recruits YY1 to the LTR via the zinc fingers of YY1. The first two zinc fingers were observed to be sufficient for this interaction in vitro. A mutant of LSF incapable of binding DNA blocked repression. Like other transcriptional repressors, YY1 can function via recruitment of histone deacetylase (HDAC). We find that HDAC1 copurifies with the LTR-binding YY1-LSF repressor complex, the domain of YY1 that interacts with HDAC1 is required to repress the HIV-1 promoter, expression of HDAC1 augments repression of the LTR by YY1, and the deacetylase inhibitor trichostatin A blocks repression mediated by YY1. This novel link between HDAC recruitment and inhibition of HIV-1 expression by YY1 and LSF, in the natural context of a viral promoter integrated into chromosomal DNA, is the first demonstration of a molecular mechanism of repression of HIV-1. YY1 and LSF may establish transcriptional and virological latency of HIV, a state that has recently been recognized in vivo and has significant implications for the long-term treatment of AIDS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888618      PMCID: PMC112196          DOI: 10.1128/jvi.74.15.6790-6799.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  A bioassay for HIV-1 based on Env-CD4 interaction.

Authors:  V Ciminale; B K Felber; M Campbell; G N Pavlakis
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

Review 2.  The price of repression.

Authors:  A D Johnson
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

Review 3.  Chromatin structure and RNA polymerase II connection: implications for transcription.

Authors:  K Struhl
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

4.  Characterization of functional domains within the multifunctional transcription factor, YY1.

Authors:  S Bushmeyer; K Park; M L Atchison
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

5.  Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity.

Authors:  W M Yang; C J Inouye; E Seto
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

6.  Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.

Authors:  J S Lee; K M Galvin; R H See; R Eckner; D Livingston; E Moran; Y Shi
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

7.  Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB.

Authors:  Q Zhou; R W Gedrich; D A Engel
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro.

Authors:  M J Pazin; P L Sheridan; K Cannon; Z Cao; J G Keck; J T Kadonaga; K A Jones
Journal:  Genes Dev       Date:  1996-01-01       Impact factor: 11.361

9.  Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Authors:  C Van Lint; S Emiliani; M Ott; E Verdin
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

10.  In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

Authors:  T W Chun; D Finzi; J Margolick; K Chadwick; D Schwartz; R F Siliciano
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  191 in total

1.  Identification of T cell-signaling pathways that stimulate latent HIV in primary cells.

Authors:  David G Brooks; Philip A Arlen; Lianying Gao; Christina M R Kitchen; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

2.  Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Authors:  Marina Lusic; Alessandro Marcello; Anna Cereseto; Mauro Giacca
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 3.  HIV latency.

Authors:  Robert F Siliciano; Warner C Greene
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

4.  Combinatorial latency reactivation for HIV-1 subtypes and variants.

Authors:  John C Burnett; Kwang-Il Lim; Arash Calafi; John J Rossi; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.

Authors:  Hao Yin; Yuhao Zhang; Xin Zhou; Huanzhang Zhu
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

6.  Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Authors:  Malini Natarajan; Gillian M Schiralli Lester; Chanhyo Lee; Anamika Missra; Gregory A Wasserman; Martin Steffen; David S Gilmour; Andrew J Henderson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

Review 7.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

8.  In utero activation of fetal memory T cells alters host regulatory gene expression and affects HIV susceptibility.

Authors:  Kevin L Steiner; Indu Malhotra; Peter L Mungai; Eric M Muchiri; Arlene E Dent; Christopher L King
Journal:  Virology       Date:  2012-01-26       Impact factor: 3.616

9.  Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid.

Authors:  Nancie M Archin; Amy Espeseth; Daniel Parker; Manzoor Cheema; Daria Hazuda; David M Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

10.  Determinants of the establishment of human immunodeficiency virus type 1 latency.

Authors:  Alexandra Duverger; Jennifer Jones; Jori May; Frederic Bibollet-Ruche; Frederic A Wagner; Randall Q Cron; Olaf Kutsch
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.